For more than 18 years, Nutranomics has worked to establish itself as a leading brand of vitamins and supplements. What sets the company’s products apart from 95 percent of multi-vitamins on the market today is that Nutranomics’ products are plant and food-based vitamins and supplements packed with ingredients designed to nourish and repair the body at the cellular level.
Nearly all multi-vitamins on the market are isolated and/or synthetic, which hampers the potency and efficacy of the vitamin, as well as the human body’s ability to absorb them. Nutranomics’ products, however, are based on the company’s patented Assimilation Enhancing System® (AES), an all-natural, patented system increasing nutrient bioavailability and decreasing the digestive burden as it aids in all stages of digestion.
To ensure potency, purity, and quality of products, Nutranomics has its own quality team that carefully selects, tests, and approves its raw materials and suppliers. The company’s products are then manufactured and sold on an international scale, meeting even the high standards of more discerning markets such as Japan. All facilities are cGMP compliant and FDA-approved.
In January, Nutranomics issued news regarding its ongoing expansion strategy in collaboration with UNO International Corp., a health and natural products distributor and the largest multi-level marketing (MLM) company in the Philippines. UNO currently has nearly 500,000 independent distributors around the world.
The goal is to leverage the strength in Nutranomics’ R&D and strong footing in UNO’s distribution to extend global awareness and reach. UNO recently purchased 20,000 bottles of Nutranomics’ enzyme product which will be sold through UNO’s expansive distribution network.
In a separate recent transaction earlier this year, Nutronomics received a repeat purchase order from one of the world’s largest essential oil direct sales distribution companies. This latest purchase order is for three separate Nutranomics products and constitutes more than $240,000 in revenue for the company.
At the start of 2014, Nutranomics reported financials for Q1 ended October 31, 2013, recording a smaller loss than expected at $220,191 vs. profit of $68,366 in Q4. Regarding the Q1 loss, company CEO Dr. Tracy Gibbs in a news release cited steep costs of going public and corporate distractions amid audit and regulatory compliance responsibilities, but said the company’s new sales teams are now focused and aligned with the overarching expansion strategy.
Per its Q1 10-K filing, the company’s inventory stands at $296,547, up from $276,477 in the prior quarter. Cash and cash equivalents also increased vs. the previous quarter, currently at $309,000. The company anticipates that moving forward it will post positive financial results reflecting expansion efforts and beefed up sales.
For more information about the company visit www.neutracorp.com
Let us hear your thoughts: NutraNomics, Inc. Message Board
